These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 17521311
1. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Pradalier A, Neukirch C, Dreyfus I, Devillier P. Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311 [Abstract] [Full Text] [Related]
2. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Meltzer EO, Jalowayski AA, Vogt K, Iezzoni D, Harris AG. Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861 [Abstract] [Full Text] [Related]
6. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review. Bachert C, van Cauwenberge P. Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184 [Abstract] [Full Text] [Related]
7. [The effect of desloratadine on quality of life of patients with seasonal allergic rhinitis]. Li Y, Liu F. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(10):439-42. PubMed ID: 18720881 [Abstract] [Full Text] [Related]
8. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Berger WE, Schenkel EJ, Mansfield LE, Desloratadine Study Group. Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207 [Abstract] [Full Text] [Related]
9. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Raphael GD, Angello JT, Wu MM, Druce HM. Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933 [Abstract] [Full Text] [Related]
10. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Berger WE, White MV, Rhinitis Study Group. Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117 [Abstract] [Full Text] [Related]
12. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis. Sullivan PW, Navaratnam P, Lorber R, Shekar T. Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438 [Abstract] [Full Text] [Related]
13. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis. Grubbe RE, Lumry WR, Anolik R. J Investig Allergol Clin Immunol; 2009 Jun; 19(2):117-24. PubMed ID: 19476015 [Abstract] [Full Text] [Related]
14. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468 [Abstract] [Full Text] [Related]
15. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P. J Investig Allergol Clin Immunol; 2008 Jan; 18(5):343-9. PubMed ID: 18973097 [Abstract] [Full Text] [Related]
16. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Canonica GW, Tarantini F, Compalati E, Penagos M. Allergy; 2007 Apr; 62(4):359-66. PubMed ID: 17362245 [Abstract] [Full Text] [Related]
17. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U. Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441 [Abstract] [Full Text] [Related]
18. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients. Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A, Bilastine International Working Group. Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976 [Abstract] [Full Text] [Related]